MorphoSys and HIBio Enter Into Equity Participation and Lice

Press release content from Business Wire. The AP news staff was not involved in its creation.

Related Keywords

Germany , Taiwan , United States , Hong Kong , United Kingdom , Planegg , Bayern , Massachusetts , China , Boston , California , Canada , South Korea , London , City Of , Macau , San Francisco , Julia Neugebauer , Paul Berns , Piper Evans , Eamonn Nolan , Travis Murdoch , Myles Clouston , Morgan Warners , Thomas Biegi , Jean Paul Kress , Xencor Inc , Linkedin , Twitter , Drug Administration , Nasdaq , Exchange Commission , Human Immunology Biosciences Inc , Goodwin Procter , Human Immunology Biosciences , South San Francisco Based , Chief Executive Officer , Managing Director , Greater China , Membranous Nephropathy , I Mab Biopharma , Mainland China , Systemic Lupus , Antibody Dependent Cell Mediated Cytotoxicity , Antibody Dependent Cellular Phagocytosis , Immunology Biosciences , Monograph Capital , Morphosy Annual Report , Business Wire , Politics , Technology , Health , Biotechnology , Morphosys Ag , Business ,